It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
B cells and T cells collaborate in multiple sclerosis (MS) pathogenesis. IgH[MOG] mice possess a B cell repertoire skewed to recognize myelin oligodendrocyte glycoprotein (MOG). Here, we show that upon immunization with the T cell-obligate autoantigen, MOG[35-55], IgH[MOG] mice develop rapid and exacerbated experimental autoimmune encephalomyelitis (EAE) relative to wildtype (WT) counterparts, characterized by aggregation of T and B cells in the IgH[MOG] meninges and by CD4+ T helper 17 (Th17) cells in the CNS. Production of the Th17 maintenance factor IL-23 is observed from IgH[MOG] CNS-infiltrating and meningeal B cells, and in vivo blockade of IL-23p19 attenuates disease severity in IgH[MOG] mice. In the CNS parenchyma and dura mater of IgH[MOG] mice, we observe an increased frequency of CD4+PD-1+CXCR5- T cells that share numerous characteristics with the recently described T peripheral helper (Tph) cell subset. Further, CNS-infiltrating B and Tph cells from IgH[MOG] mice show increased reactive oxygen species (ROS) production. Meningeal inflammation, Tph-like cell accumulation in the CNS and B/Tph cell production of ROS were all reduced upon p19 blockade. Altogether, MOG-specific B cells promote autoimmune inflammation of the CNS parenchyma and meninges in an IL-23-dependent manner.
B cells are crucial in multiple sclerosis (MS) pathology but the mechanisms are incompletely understood. In a mouse model of MS, the authors show that B cells make IL-23, and that IL-23 invokes meningeal inflammation and CNS presence of T peripheral helper cells.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details




1 Centre de recherche du Centre hospitalier universitaire (CHU) de Québec – Université Laval, Pavillon CHUL, axe Neurosciences, Quebec City, Canada (GRID:grid.411081.d) (ISNI:0000 0000 9471 1794)
2 University Health Network, Krembil Research Institute, Toronto, Canada (GRID:grid.231844.8) (ISNI:0000 0004 0474 0428)
3 Memorial University of Newfoundland, Division of BioMedical Sciences, St. John’s, Canada (GRID:grid.25055.37) (ISNI:0000 0000 9130 6822); Memorial University of Newfoundland, Department of Neurology, Faculty of Medicine, St. John’s, Canada (GRID:grid.25055.37) (ISNI:0000 0000 9130 6822)
4 University Health Network, Krembil Research Institute, Toronto, Canada (GRID:grid.231844.8) (ISNI:0000 0004 0474 0428); University of Toronto, Department of Immunology, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938)
5 Centre de recherche du Centre hospitalier universitaire (CHU) de Québec – Université Laval, Pavillon CHUL, axe Endocrinologie et nephrologie, Quebec City, Canada (GRID:grid.411081.d) (ISNI:0000 0000 9471 1794)
6 Centre de recherche du Centre hospitalier universitaire (CHU) de Québec – Université Laval, Pavillon CHUL, axe Endocrinologie et nephrologie, Quebec City, Canada (GRID:grid.411081.d) (ISNI:0000 0000 9471 1794); Laval University, Faculty of Pharmacy, Quebec City, Canada (GRID:grid.23856.3a) (ISNI:0000 0004 1936 8390)
7 Centre de recherche du Centre hospitalier universitaire (CHU) de Québec – Université Laval, Pavillon CHUL, axe Neurosciences, Quebec City, Canada (GRID:grid.411081.d) (ISNI:0000 0000 9471 1794); Laval University, Department of Molecular Medicine, Faculty of Medicine, Quebec City, Canada (GRID:grid.23856.3a) (ISNI:0000 0004 1936 8390)
8 Centre de recherche du Centre hospitalier universitaire (CHU) de Québec – Université Laval, Pavillon CHUL, axe Endocrinologie et nephrologie, Quebec City, Canada (GRID:grid.411081.d) (ISNI:0000 0000 9471 1794); Laval University, Department of Molecular Medicine, Faculty of Medicine, Quebec City, Canada (GRID:grid.23856.3a) (ISNI:0000 0004 1936 8390)